Verition Fund Management LLC Bausch Health Companies Inc. Transaction History

Verition Fund Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $1.07 Million - $3.58 Million	-151,368 Reduced 91.28%	14,456 $121,000
Q1 2022 May 13, 2022	BUY	$21.6 - $27.79 $1.56 Million - $2.01 Million	72,385 Added 77.47%	165,824 $3.79 Million
Q4 2021 May 03, 2022	SELL	$23.0 - $29.01 $1.15 Million - $1.45 Million	-50,000 Reduced 34.86%	93,439 $2.58 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $1.49 Million - $1.88 Million	64,766 Added 82.32%	143,439 $3.96 Million
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $1.97 Million - $2.36 Million	78,673 New	78,673 $2.19 Million
Q1 2019 May 15, 2019	SELL	$20.23 - $26.29 $441,196 - $573,358	-21,809 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$17.64 - $28.32 $384,710 - $617,630	21,809 New	21,809 $403,000

275

279M

5.68M

17.4M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.99B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.